CORONA, Calif., May 01, 2017 -- Acology Inc. (OTC:ACOL) announced today that they have entered negotiations to purchase EZ Health Solutions. The purpose of the acquisition is to create a new division in the company that will move strongly into the CBD extract industry.
Industry experts predict that associated hemp and CBD extract sales will top $1.8B by 2020 with CBD-associated products experiencing a yearly 53% AGR. Acology management intends to quickly add this new division to the company, joining their pharmaceutical container, hydroponics, printing and advertising divisions.
For 22 years EZ Health Solutions (www.ez-healthsolutions.com) has led the natural supplements industry in quality and value. Led by Rajbir Husson, who brings more than 30 years of experience in compounding nutraceutical diet solutions and health supplements, Acology anticipates the research and development of new product lines in the areas of CBD infused water, super-food supplements, super-green energy products and healthy joint support creams and oils. Acology’s new line of products are designed to appeal to a wide range of customers and every product will be entirely natural and pest, chemical and toxin free.
Acology is in the midst of the most profitable year in its 6-year history and continues to set new sales records. Associated medical and MMJ support products, including hydroponics, merchandizing, printing and advertising are all ascending sharply. With the addition of this new division the company continues to express confidence and will continue its expansion in the foreseeable future.
For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.
Acology trades on the OTC under the call letters ACOL. The company’s websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome. Please send all inquiries to [email protected] or call (844) ACOLOGY (844-226-5649). Ask for Jack Rein, National Services Director. Acology can also be accessed through Twitter and Instagram at @Acologyinc
This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as “anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all his or her investment.


Netflix Stock Slips After Earnings as Soft 2026 Guidance Overshadows Subscriber Milestone
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years
Lynas Rare Earths Shares Surge as Quarterly Revenue Jumps on Strong Prices
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand
Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Elon Musk Says Tesla Cybercab and Optimus Production Will Start Slowly Before Rapid Growth
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 



